29.07.2014 • NewsDede WillamsPharmaPharmaceuticals

US-UK Deal Creates Expanded Drug Services Player

Pharmaceutical services company Packaging Coordinators Inc. (PCI) said it has reached a "definitive agreement" to acquire Penn Pharmaceutical Services based in Tredegar, Wales, with regional offices in New Hope, Pennsylvania, USA, and Tokyo, Japan. 

UK press reports said the deal is worth £127 million

The Welsh company offers both drug development and manufacturing services, including clinical and commercial dosage form manufacturing. Its activities also include clinical packaging, labeling and global storage, distribution and return drug services. 

PCI said Penn Pharma's drug development, manufacturing, and packaging services complement its own growth in clinical trial and commercial supply services, having expanded both its global operations in North America and Europe. 

The Philadelphia-based company has announced several key investments recently, including cold chain infrastructure expansions for both storage and logistics as well as support for refrigerated packaging operations.  PCI will also open a 97,000 square foot North American Storage and Distribution facility for investigational products in September of this year.

Penn Pharma also has made recent investments in assets, opening a new purpose-built contained manufacturing facility to serve market needs for specialist containment solutions for development and manufacturing of solid oral dose products containing highly potent compounds.

In 2014, Penn launched a capacity expansion project for large-scale commercial manufacturing and packaging.

PCI is principally owned by Frazier Healthcare, with shares owned by QIC Global Private Equity, Greenspring Associates and Thomas, McNerney & Partners. 

Penn Pharma is privately owned and operates from a single site facility in South Wales, UK where it employs around 300 staff.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.